The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels
Aim: Insufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during isch...
Gespeichert in:
Veröffentlicht in: | Cardiovascular Journal of Africa 2017-11, Vol.28 (6), p.389-396 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 396 |
---|---|
container_issue | 6 |
container_start_page | 389 |
container_title | Cardiovascular Journal of Africa |
container_volume | 28 |
creator | Yardim, Meltem Kalkan, Ali Kemal Aydin, Suna Eren, Mehmet Nesimi Temizturk, Zeki Aydin, Suleyman Azboy, Davut Kuloglu, Tuncay |
description | Aim: Insufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during ischaemia, is unknown. Iloprost and sildenafil are two pharmaceutical agents that mediate the resumption of reperfusion (blood supply) via vasodilatation during ischaemic conditions. Our study aimed to explore the effects of iloprost and sildenafil on irisin levels in the heart, liver and kidney tissues and whether these pharmaceutical agents had any impact on serum irisin and nitric oxide levels in rats with induced experimental myocardial ischaemia. Methods: The study included adult male Sprague-Dawley rats aged 10 months and weighing between 250 and 280 g. The animals were randomly allocated to eight groups, with five rats in each group. The groups were: sham (control), iloprost (ILO), sildenafil (SIL), ILO + SIL, myocardial ischaemia (MI), MI + ILO, MI + SIL and MI + ILO + SIL. The treatment protocols were implemented before inducing ischaemia, which was done by occluding the left coronary artery with a plastic ligature for 30 minutes. Following the reperfusion procedure, all rats were sacrificed after 24 hours, and their heart, liver and kidney tissues and blood samples were collected for analyses. An immunohistochemical method was used to measure the change in irisin levels, the ELISA method to quantify blood irisin levels, and Griess’ assay to determine nitric oxide (NO) levels in the serum and tissue. Myocardial ischaemia was confirmed based on the results of Masson’s trichrome staining, as well as levels of troponin and creatine kinase MB. Results: Irisin levels in biological tissue and serum dropped statistically significantly in the ischaemic group (MI), but were restored with ILO and SIL administration. Individual SIL administration was more potently restorative than individual ILO administration or the combined administration of the two agents. NO level, on the other hand, showed the opposite tendency, reaching the highest level in the MI group, and falling with the use of pharmaceutical agents. Conclusions: Individual or combined administration of ILO and SIL reduced myocardial ischaemia and NO levels, and increased irisin levels. Elevated levels of irisin obtained by drug administration could possibly contribute to accelerated wound recovery by local |
doi_str_mv | 10.5830/CVJA-2017-025 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5885053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sabinet_id>10520/EJC-b2be3f645</sabinet_id><sourcerecordid>2032684254</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-3930a6df337fc2070c48405d80e91a03d82e52718a9df15009104ea218919d703</originalsourceid><addsrcrecordid>eNpdkc1rFDEYhwdRbK0evUrAi0JH33zNJJdCWepHKXipXkM2ecdNySTrZLZY_OfNdNeinhKSJz_eX56meUnhnVQc3q--XZ63DGjfApOPmmPaKWihF_Jx3WstW6o0O2qelXIDwJjq5dPmiCkNnWT6uPl1vUGCw4BuJnkgIebtlMtMbPKkhOgx2SHEU2JjTnh_GhJxeVyHZOeQ0ynJiYx32dnJBxtJKG5jcQz2nk1hnoIj-Wfwh8dTKDUg4i3G8rx5MthY8MVhPWm-fri4Xn1qr758_Lw6v2qdEHpuueZgOz9w3g-OQQ9OKAHSK0BNLXCvGErWU2W1H6gE0BQEWlaLU-174CfN2T53u1uP6B2mebLRbKcw2unOZBvMvzcpbMz3fGukUhIkrwFvDgFT_rHDMpux9sQYbcK8K4ZqvpBaLOjr_9CbvJtSrWcYcNYpwaSoVLunXP3sMuHwMAwFs2g1i1azaDVVa-Vf_d3ggf7jsQJv90Cx1QzOplisbI2TDMzF5cqs2Rr50AnJfwPBrqsM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2032684254</pqid></control><display><type>article</type><title>The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Yardim, Meltem ; Kalkan, Ali Kemal ; Aydin, Suna ; Eren, Mehmet Nesimi ; Temizturk, Zeki ; Aydin, Suleyman ; Azboy, Davut ; Kuloglu, Tuncay</creator><creatorcontrib>Yardim, Meltem ; Kalkan, Ali Kemal ; Aydin, Suna ; Eren, Mehmet Nesimi ; Temizturk, Zeki ; Aydin, Suleyman ; Azboy, Davut ; Kuloglu, Tuncay</creatorcontrib><description>Aim: Insufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during ischaemia, is unknown. Iloprost and sildenafil are two pharmaceutical agents that mediate the resumption of reperfusion (blood supply) via vasodilatation during ischaemic conditions. Our study aimed to explore the effects of iloprost and sildenafil on irisin levels in the heart, liver and kidney tissues and whether these pharmaceutical agents had any impact on serum irisin and nitric oxide levels in rats with induced experimental myocardial ischaemia. Methods: The study included adult male Sprague-Dawley rats aged 10 months and weighing between 250 and 280 g. The animals were randomly allocated to eight groups, with five rats in each group. The groups were: sham (control), iloprost (ILO), sildenafil (SIL), ILO + SIL, myocardial ischaemia (MI), MI + ILO, MI + SIL and MI + ILO + SIL. The treatment protocols were implemented before inducing ischaemia, which was done by occluding the left coronary artery with a plastic ligature for 30 minutes. Following the reperfusion procedure, all rats were sacrificed after 24 hours, and their heart, liver and kidney tissues and blood samples were collected for analyses. An immunohistochemical method was used to measure the change in irisin levels, the ELISA method to quantify blood irisin levels, and Griess’ assay to determine nitric oxide (NO) levels in the serum and tissue. Myocardial ischaemia was confirmed based on the results of Masson’s trichrome staining, as well as levels of troponin and creatine kinase MB. Results: Irisin levels in biological tissue and serum dropped statistically significantly in the ischaemic group (MI), but were restored with ILO and SIL administration. Individual SIL administration was more potently restorative than individual ILO administration or the combined administration of the two agents. NO level, on the other hand, showed the opposite tendency, reaching the highest level in the MI group, and falling with the use of pharmaceutical agents. Conclusions: Individual or combined administration of ILO and SIL reduced myocardial ischaemia and NO levels, and increased irisin levels. Elevated levels of irisin obtained by drug administration could possibly contribute to accelerated wound recovery by local heat production. Sildenafil was more effective than iloprost in eliminating ischaemia and may be the first choice in offsetting the effects of ischaemia in the future.</description><identifier>ISSN: 1995-1892</identifier><identifier>EISSN: 1680-0745</identifier><identifier>DOI: 10.5830/CVJA-2017-025</identifier><identifier>PMID: 28906529</identifier><language>eng</language><publisher>South Africa: Clinics Cardive Publishing</publisher><subject>Adenosine Triphosphate - metabolism ; Animals ; Biochemistry ; Cardiovascular Topics ; Disease Models, Animal ; Education ; Energy Metabolism - drug effects ; Experiments ; Fibronectins - blood ; Glucose ; Heart surgery ; Hospitals ; Iloprost ; Iloprost - pharmacology ; Irisin ; Kidney - drug effects ; Kidney - metabolism ; Liver ; Liver - drug effects ; Liver - metabolism ; Male ; Medicine ; Myocardial ischaemia–reperfusion ; Myocardial Ischemia - blood ; Myocardial Ischemia - drug therapy ; Myocardial Ischemia - pathology ; Myocardial Ischemia - physiopathology ; Myocardial Reperfusion Injury - blood ; Myocardial Reperfusion Injury - pathology ; Myocardial Reperfusion Injury - physiopathology ; Myocardial Reperfusion Injury - prevention & control ; Myocardium - metabolism ; Myocardium - pathology ; Nitric oxide ; Nitric Oxide - blood ; Pharmaceuticals ; Proteins ; Rats, Sprague-Dawley ; Rodents ; Sildenafil ; Sildenafil Citrate - pharmacology ; Vasodilation - drug effects ; Vasodilator Agents - pharmacology ; Wound healing</subject><ispartof>Cardiovascular Journal of Africa, 2017-11, Vol.28 (6), p.389-396</ispartof><rights>Copyright © 2015 Clinics Cardive Publishing. This work is licensed under the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/3.0/ ) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2015 Clinics Cardive Publishing 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-3930a6df337fc2070c48405d80e91a03d82e52718a9df15009104ea218919d703</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885053/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885053/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28906529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yardim, Meltem</creatorcontrib><creatorcontrib>Kalkan, Ali Kemal</creatorcontrib><creatorcontrib>Aydin, Suna</creatorcontrib><creatorcontrib>Eren, Mehmet Nesimi</creatorcontrib><creatorcontrib>Temizturk, Zeki</creatorcontrib><creatorcontrib>Aydin, Suleyman</creatorcontrib><creatorcontrib>Azboy, Davut</creatorcontrib><creatorcontrib>Kuloglu, Tuncay</creatorcontrib><title>The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels</title><title>Cardiovascular Journal of Africa</title><addtitle>Cardiovasc J Afr</addtitle><description>Aim: Insufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during ischaemia, is unknown. Iloprost and sildenafil are two pharmaceutical agents that mediate the resumption of reperfusion (blood supply) via vasodilatation during ischaemic conditions. Our study aimed to explore the effects of iloprost and sildenafil on irisin levels in the heart, liver and kidney tissues and whether these pharmaceutical agents had any impact on serum irisin and nitric oxide levels in rats with induced experimental myocardial ischaemia. Methods: The study included adult male Sprague-Dawley rats aged 10 months and weighing between 250 and 280 g. The animals were randomly allocated to eight groups, with five rats in each group. The groups were: sham (control), iloprost (ILO), sildenafil (SIL), ILO + SIL, myocardial ischaemia (MI), MI + ILO, MI + SIL and MI + ILO + SIL. The treatment protocols were implemented before inducing ischaemia, which was done by occluding the left coronary artery with a plastic ligature for 30 minutes. Following the reperfusion procedure, all rats were sacrificed after 24 hours, and their heart, liver and kidney tissues and blood samples were collected for analyses. An immunohistochemical method was used to measure the change in irisin levels, the ELISA method to quantify blood irisin levels, and Griess’ assay to determine nitric oxide (NO) levels in the serum and tissue. Myocardial ischaemia was confirmed based on the results of Masson’s trichrome staining, as well as levels of troponin and creatine kinase MB. Results: Irisin levels in biological tissue and serum dropped statistically significantly in the ischaemic group (MI), but were restored with ILO and SIL administration. Individual SIL administration was more potently restorative than individual ILO administration or the combined administration of the two agents. NO level, on the other hand, showed the opposite tendency, reaching the highest level in the MI group, and falling with the use of pharmaceutical agents. Conclusions: Individual or combined administration of ILO and SIL reduced myocardial ischaemia and NO levels, and increased irisin levels. Elevated levels of irisin obtained by drug administration could possibly contribute to accelerated wound recovery by local heat production. Sildenafil was more effective than iloprost in eliminating ischaemia and may be the first choice in offsetting the effects of ischaemia in the future.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Animals</subject><subject>Biochemistry</subject><subject>Cardiovascular Topics</subject><subject>Disease Models, Animal</subject><subject>Education</subject><subject>Energy Metabolism - drug effects</subject><subject>Experiments</subject><subject>Fibronectins - blood</subject><subject>Glucose</subject><subject>Heart surgery</subject><subject>Hospitals</subject><subject>Iloprost</subject><subject>Iloprost - pharmacology</subject><subject>Irisin</subject><subject>Kidney - drug effects</subject><subject>Kidney - metabolism</subject><subject>Liver</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Medicine</subject><subject>Myocardial ischaemia–reperfusion</subject><subject>Myocardial Ischemia - blood</subject><subject>Myocardial Ischemia - drug therapy</subject><subject>Myocardial Ischemia - pathology</subject><subject>Myocardial Ischemia - physiopathology</subject><subject>Myocardial Reperfusion Injury - blood</subject><subject>Myocardial Reperfusion Injury - pathology</subject><subject>Myocardial Reperfusion Injury - physiopathology</subject><subject>Myocardial Reperfusion Injury - prevention & control</subject><subject>Myocardium - metabolism</subject><subject>Myocardium - pathology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - blood</subject><subject>Pharmaceuticals</subject><subject>Proteins</subject><subject>Rats, Sprague-Dawley</subject><subject>Rodents</subject><subject>Sildenafil</subject><subject>Sildenafil Citrate - pharmacology</subject><subject>Vasodilation - drug effects</subject><subject>Vasodilator Agents - pharmacology</subject><subject>Wound healing</subject><issn>1995-1892</issn><issn>1680-0745</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkc1rFDEYhwdRbK0evUrAi0JH33zNJJdCWepHKXipXkM2ecdNySTrZLZY_OfNdNeinhKSJz_eX56meUnhnVQc3q--XZ63DGjfApOPmmPaKWihF_Jx3WstW6o0O2qelXIDwJjq5dPmiCkNnWT6uPl1vUGCw4BuJnkgIebtlMtMbPKkhOgx2SHEU2JjTnh_GhJxeVyHZOeQ0ynJiYx32dnJBxtJKG5jcQz2nk1hnoIj-Wfwh8dTKDUg4i3G8rx5MthY8MVhPWm-fri4Xn1qr758_Lw6v2qdEHpuueZgOz9w3g-OQQ9OKAHSK0BNLXCvGErWU2W1H6gE0BQEWlaLU-174CfN2T53u1uP6B2mebLRbKcw2unOZBvMvzcpbMz3fGukUhIkrwFvDgFT_rHDMpux9sQYbcK8K4ZqvpBaLOjr_9CbvJtSrWcYcNYpwaSoVLunXP3sMuHwMAwFs2g1i1azaDVVa-Vf_d3ggf7jsQJv90Cx1QzOplisbI2TDMzF5cqs2Rr50AnJfwPBrqsM</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Yardim, Meltem</creator><creator>Kalkan, Ali Kemal</creator><creator>Aydin, Suna</creator><creator>Eren, Mehmet Nesimi</creator><creator>Temizturk, Zeki</creator><creator>Aydin, Suleyman</creator><creator>Azboy, Davut</creator><creator>Kuloglu, Tuncay</creator><general>Clinics Cardive Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171101</creationdate><title>The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels</title><author>Yardim, Meltem ; Kalkan, Ali Kemal ; Aydin, Suna ; Eren, Mehmet Nesimi ; Temizturk, Zeki ; Aydin, Suleyman ; Azboy, Davut ; Kuloglu, Tuncay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-3930a6df337fc2070c48405d80e91a03d82e52718a9df15009104ea218919d703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Animals</topic><topic>Biochemistry</topic><topic>Cardiovascular Topics</topic><topic>Disease Models, Animal</topic><topic>Education</topic><topic>Energy Metabolism - drug effects</topic><topic>Experiments</topic><topic>Fibronectins - blood</topic><topic>Glucose</topic><topic>Heart surgery</topic><topic>Hospitals</topic><topic>Iloprost</topic><topic>Iloprost - pharmacology</topic><topic>Irisin</topic><topic>Kidney - drug effects</topic><topic>Kidney - metabolism</topic><topic>Liver</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Medicine</topic><topic>Myocardial ischaemia–reperfusion</topic><topic>Myocardial Ischemia - blood</topic><topic>Myocardial Ischemia - drug therapy</topic><topic>Myocardial Ischemia - pathology</topic><topic>Myocardial Ischemia - physiopathology</topic><topic>Myocardial Reperfusion Injury - blood</topic><topic>Myocardial Reperfusion Injury - pathology</topic><topic>Myocardial Reperfusion Injury - physiopathology</topic><topic>Myocardial Reperfusion Injury - prevention & control</topic><topic>Myocardium - metabolism</topic><topic>Myocardium - pathology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - blood</topic><topic>Pharmaceuticals</topic><topic>Proteins</topic><topic>Rats, Sprague-Dawley</topic><topic>Rodents</topic><topic>Sildenafil</topic><topic>Sildenafil Citrate - pharmacology</topic><topic>Vasodilation - drug effects</topic><topic>Vasodilator Agents - pharmacology</topic><topic>Wound healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yardim, Meltem</creatorcontrib><creatorcontrib>Kalkan, Ali Kemal</creatorcontrib><creatorcontrib>Aydin, Suna</creatorcontrib><creatorcontrib>Eren, Mehmet Nesimi</creatorcontrib><creatorcontrib>Temizturk, Zeki</creatorcontrib><creatorcontrib>Aydin, Suleyman</creatorcontrib><creatorcontrib>Azboy, Davut</creatorcontrib><creatorcontrib>Kuloglu, Tuncay</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cardiovascular Journal of Africa</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yardim, Meltem</au><au>Kalkan, Ali Kemal</au><au>Aydin, Suna</au><au>Eren, Mehmet Nesimi</au><au>Temizturk, Zeki</au><au>Aydin, Suleyman</au><au>Azboy, Davut</au><au>Kuloglu, Tuncay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels</atitle><jtitle>Cardiovascular Journal of Africa</jtitle><addtitle>Cardiovasc J Afr</addtitle><date>2017-11-01</date><risdate>2017</risdate><volume>28</volume><issue>6</issue><spage>389</spage><epage>396</epage><pages>389-396</pages><issn>1995-1892</issn><eissn>1680-0745</eissn><abstract>Aim: Insufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during ischaemia, is unknown. Iloprost and sildenafil are two pharmaceutical agents that mediate the resumption of reperfusion (blood supply) via vasodilatation during ischaemic conditions. Our study aimed to explore the effects of iloprost and sildenafil on irisin levels in the heart, liver and kidney tissues and whether these pharmaceutical agents had any impact on serum irisin and nitric oxide levels in rats with induced experimental myocardial ischaemia. Methods: The study included adult male Sprague-Dawley rats aged 10 months and weighing between 250 and 280 g. The animals were randomly allocated to eight groups, with five rats in each group. The groups were: sham (control), iloprost (ILO), sildenafil (SIL), ILO + SIL, myocardial ischaemia (MI), MI + ILO, MI + SIL and MI + ILO + SIL. The treatment protocols were implemented before inducing ischaemia, which was done by occluding the left coronary artery with a plastic ligature for 30 minutes. Following the reperfusion procedure, all rats were sacrificed after 24 hours, and their heart, liver and kidney tissues and blood samples were collected for analyses. An immunohistochemical method was used to measure the change in irisin levels, the ELISA method to quantify blood irisin levels, and Griess’ assay to determine nitric oxide (NO) levels in the serum and tissue. Myocardial ischaemia was confirmed based on the results of Masson’s trichrome staining, as well as levels of troponin and creatine kinase MB. Results: Irisin levels in biological tissue and serum dropped statistically significantly in the ischaemic group (MI), but were restored with ILO and SIL administration. Individual SIL administration was more potently restorative than individual ILO administration or the combined administration of the two agents. NO level, on the other hand, showed the opposite tendency, reaching the highest level in the MI group, and falling with the use of pharmaceutical agents. Conclusions: Individual or combined administration of ILO and SIL reduced myocardial ischaemia and NO levels, and increased irisin levels. Elevated levels of irisin obtained by drug administration could possibly contribute to accelerated wound recovery by local heat production. Sildenafil was more effective than iloprost in eliminating ischaemia and may be the first choice in offsetting the effects of ischaemia in the future.</abstract><cop>South Africa</cop><pub>Clinics Cardive Publishing</pub><pmid>28906529</pmid><doi>10.5830/CVJA-2017-025</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1995-1892 |
ispartof | Cardiovascular Journal of Africa, 2017-11, Vol.28 (6), p.389-396 |
issn | 1995-1892 1680-0745 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5885053 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adenosine Triphosphate - metabolism Animals Biochemistry Cardiovascular Topics Disease Models, Animal Education Energy Metabolism - drug effects Experiments Fibronectins - blood Glucose Heart surgery Hospitals Iloprost Iloprost - pharmacology Irisin Kidney - drug effects Kidney - metabolism Liver Liver - drug effects Liver - metabolism Male Medicine Myocardial ischaemia–reperfusion Myocardial Ischemia - blood Myocardial Ischemia - drug therapy Myocardial Ischemia - pathology Myocardial Ischemia - physiopathology Myocardial Reperfusion Injury - blood Myocardial Reperfusion Injury - pathology Myocardial Reperfusion Injury - physiopathology Myocardial Reperfusion Injury - prevention & control Myocardium - metabolism Myocardium - pathology Nitric oxide Nitric Oxide - blood Pharmaceuticals Proteins Rats, Sprague-Dawley Rodents Sildenafil Sildenafil Citrate - pharmacology Vasodilation - drug effects Vasodilator Agents - pharmacology Wound healing |
title | The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T22%3A45%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20iloprost%20and%20sildenafil,%20alone%20and%20in%20combination,%20on%20myocardial%20ischaemia%20and%20nitric%20oxide%20and%20irisin%20levels&rft.jtitle=Cardiovascular%20Journal%20of%20Africa&rft.au=Yardim,%20Meltem&rft.date=2017-11-01&rft.volume=28&rft.issue=6&rft.spage=389&rft.epage=396&rft.pages=389-396&rft.issn=1995-1892&rft.eissn=1680-0745&rft_id=info:doi/10.5830/CVJA-2017-025&rft_dat=%3Cproquest_pubme%3E2032684254%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2032684254&rft_id=info:pmid/28906529&rft_sabinet_id=10520/EJC-b2be3f645&rfr_iscdi=true |